+50% phase 1/2 trials in immunology
5 antibodies in phase 2/3
1 blockbuster approuvé
3 approved niche antibodies
30 new viable start-ups
30 company locations
2,000 direct jobs created
+ 2 billion euros in capital
Boosted by Marseille's already renowned academic and industrial pool in the immunology field, MIB intends to build on the existing momentum to make the region a hub of excellence. MIB's declared ambition to bring together researchers, practitioners and industrialists active in Marseille is the driving force behind a united and internationally recognized collaboration. Added to this ambition are clear objectives to make the MIB an economic engine for the region.
As part of the Plan Innovation Santé 2030, MIB has set objectives in line with those set by the government. To pursue projects already underway, and with a view to launching new ones, MIB's strategy is to create synergies with immunology experts beyond the Marseilles area, to accelerate the research and testing phases. A strategy of emulation that builds on national strengths and responds to local challenges, in the service of hospital patients in France.
With the aim of reinforcing French sovereignty in healthcare research, MIB is building on shared strengths to promote its expertise in the face of global bioclusters that are setting the standard for healthcare innovation. Thanks to a multi-stakeholder steering committee of committed players and structuring support from the French government, the hub is helping to promote French-style excellence worldwide, not only in research and innovation, but also in healthcare, and particularly in immunology.